Stock Analysis of NanoString Technologies Inc (NSTG) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code NSTG
Close 0.172
Change 0.101 / 142.96 %
Volume 2911.75 K
Vol Change 211736 / 7.84 %
IndustryMedical Instruments & Supplies
SectorHealthcare
AIO Strength Index
Technical StrengthNeutral
Growth Index Very Low Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Poor Stability Stock


Fundamental View of NanoString Technologies Inc


Highs/Lows of NanoString Technologies Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.071 142.96 % 1.54 % 0.190.160128-Feb-2428-Feb-24
Two Week0.071 142.96 % 3.42 % 0.190.160128-Feb-2428-Feb-24
One Month0.4001 56.89 % 5.60 % 0.550.04101-Feb-2414-Feb-24
Three Month0.5474 68.49 % 5.95 % 0.93990.04122-Dec-2314-Feb-24
Six Months2.75 93.73 % 17.48 % 3.150.04129-Aug-2314-Feb-24
One year9.76 98.23 % 27.52 % 11.020.04104-May-2314-Feb-24
Two year35.46 99.51 % 29.70 % 18.510.04111-Aug-2214-Feb-24
Five year25.47 99.32 % 85.46 % 16.470.04115-Sep-2214-Feb-24
Ten year18.9 99.09 % 182.41 % 86.420.04116-Feb-2114-Feb-24


Technical View of NanoString Technologies Inc






Charts of NanoString Technologies Inc


Returns of NanoString Technologies Inc with Peers
Period / StockNSTGMBOTGCTKPOAIBRTX
1 Week142.96%1.82%-10.75%3.07%-5.11%
1 Mth-56.89%4.46%-30.07%29.36%-6.47%
3 Mth-68.49%-27.12%108.33%-48.31%-12.75%
6mth-93.73%-31.88%225.73%-41.26%-30.11%
1 Year-98.23%-21.00%9.29%-41.87%-74.31%
2 Year-99.51%-81.20%-83.77%-77.72%-64.38%
5 Years-99.32%-87.21%-77.38%-98.67%-99.91%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of NanoString Technologies Inc with Peers
Ratio / StockNSTGMBOTGCTKPOAIBRTX
PE-0.0489-273.60690.80-0.459-0.984
P/B0.578335.592529.270.5930.459
ROA-51.29-95.19185.18-82.84-43.56
ROE-1182.06-122.66116.24-129.12-46.67
Debt To Equity2.800.04240.0610.0630.0141
Revenue127262 K
12.28 %
0
%
0
%
1808.53 K
20.13 %
130200
8.68 %
Net Income-159543.00 K
38.43 %
-10584.00 K
108.97 %
-5972.00 K
34.57 %
-18424.73 K
28.41 %
-15937.82 K
13.83 %


Technicals of NanoString Technologies Inc with Peers
Technical / StockNSTGMBOTGCTKPOAIBRTX-
ADX15.7017.7622.3713.9915.14
CMF-0.408-0.059-0.2130.0486-0.058
MFI86.2441.3451.2897.4190.83
RSI40.9045.1247.2447.8544.85
MACD Abv SignalFalseTrueFalseTrueFalse
Price Above 50 MAFalseFalseTrueFalseFalse-
Price Above 200 MAFalseFalseTrueFalseFalse-


About : NanoString Technologies Inc


Address : 530 Fairview Avenue North, Seattle, WA, United States, 98109
Tel : 206 378 6266
URL : https://www.nanostring.com
Code : NSTG, ISIN : US63009R1095, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 26_Jun_2013
Employee Count : 550

NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaboration with Lam Research Corporation for the development of NGS sequencing platform and related assays; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer, as well as collaboration with Stanford Medicine, Acrobat Genomics, and Illumina Accelerator to discover new drug targets for gene editing-based therapeutics. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington. On February 4, 2024, NanoString Technologies, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bank


Note : All Data Generated at the End of Trading Hours (EOD Data)